In a remarkable leap forward for synthetic biology, the AI model ESM3, developed by Evolutionary Scale, has achieved a significant milestone. By simulating half a billion years of evolutionary ...

Protein engineering will be critical to creating the next generation of therapeutics, chemicals, materials, and food. Artificial intelligence is poised to have a transformational impact on protein ...

Therapeutic protein design is evolving—and it is doing so in more than one sense of that word. Protein design is being guided by artificial intelligence (AI), which drug developers are using to ...

Nature is pretty good at designing proteins. Scientists are even better. But artificial intelligence holds the promise of improving proteins many times over. Medical applications for such “designer ...

In this episode of eSpeaks, Jennifer Margles, Director of Product Management at BMC Software, discusses the transition from traditional job scheduling to the era of the autonomous enterprise. eSpeaks’ ...

Antibody engineering enables the generation of novel and diverse antibody constructs. The development of therapeutic antibodies is highly dependent on antibody engineering, whether for the generation ...

WHAT: The protein sequencing company, Quantum-Si, will discuss their novel next-generation protein sequencing platform, Platinum™, and how it can be used to identify proteins with single-molecule ...

Optimized chemistry enables direct synthesis of up to 500 bp double stranded fragments “Using our chemical synthesis platform we are able to directly synthesize Twist Multiplexed Gene Fragments as ...

Many pharmaceutical companies are using computer modeling programs to help design classes of drugs to fit into protein active sites. Researchers at Duke University are doing the opposite to help ...